اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدOptimization of a multipoint plastic scintillator dosimeter for high dose rate brachytherapy
70
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Purpose: This study aims to optimize and characterize the response of a mPSD for in vivo dosimetry in HDR brachytherapy. Methods: An exhaustive analysis was carried out in order to obtain an optimized mPSD design that maximize the scintillation light collection produced by the interaction of ionizing photons. Several mPSD prototypes were built and tested in order to determine the appropriate order of scintillators relative to the photodetector, as well as their length as a function of the scintillation light emitted. Scintillators BCF-60, BCF-12 and BCF-10 constituted the mPSD sensitive volume.Each scintillator contribution to the total spectrum was determined by irradiations in the low energy range.For the best mPSD design, a numerical optimization was done in order to select the optical components that better match the light emission profile. The optimized dosimetric system was used for HDR brachytherapy dose determination. The system performance was quantified in term of signal to noise ratio and signal to background ratio. Results: It was determined that BCF-60 should be placed at the distal position, BCF-12 in the center and BCF-10 at proximal position with respect to the photodetector.This configuration allowed for optimized light transmission through the collecting fiber, avoiding inter-scintillator excitation and self-absorption effects.The optimized luminescence system allowed for signal deconvolution using a multispectral approach, extracting the dose to each element while taking into account Cerenkov stem effect.Differences between the mPSD measurements and TG-43 remain below 5%. In all measurement conditions, the system was able to properly differentiate the produced scintillation signal from the background one. Conclusions: A mPSD was constructed and optimized for HDR brachytherapy dosimetry, enabling real time dose determination, up to 6.5cm from the 192Ir source.
قيم البحث
اقرأ أيضاً
High dose-rate brachytherapy (HDRBT) is widely used for gynecological cancer treatment. Although commercial treatment planning systems (TPSs) have inverse optimization modules, it takes several iterations to adjust planning objectives to achieve a sa
tisfactory plan. Interactive plan-modification modules enable modifying the plan and visualizing results in real time, but they update plans based on simple geometrical or heuristic algorithms, which cannot ensure resulting plan optimality. This project develops an interactive plan optimization module for HDRBT of gynecological cancer. By efficiently solving an optimization problem in real time, it allows a user to visualize a plan and interactively modify it to improve quality. We formulated an optimization problem with an objective function containing a weighted sum of doses to normal organs subject to user-specified target coverage. A user interface was developed that allows a user to adjust organ weights using scroll bars. With a simple mouse click, the optimization problem is solved in seconds with a highly efficient alternating-direction method of multipliers and a warm start optimization strategy. Resulting clinically relevant D2cc of organs are displayed immediately. This allows a user to intuitively adjust plans with satisfactory quality. We tested the effectiveness of our development in cervix cancer cases treated with a tandem-and-ovoid applicator. It took a maximum of 3 seconds to solve the optimization problem in each instance. With interactive optimization capability, a satisfactory plan can be obtained in <1 min. In our clinic, although the time for plan adjustment was typically <10min with simple interactive plan modification tools in TPS, the resulting plans do not ensure optimality. Our plans achieved on average 5% lower D2cc than clinical plans, while maintaining target coverage.
Purpose: To determine whether alternative HDR prostate brachytherapy catheter patterns can result in improved dose distributions while providing better access and reducing trauma. Methods: Prostate HDR brachytherapy uses a grid of parallel needle p
ositions to guide the catheter insertion. This geometry does not easily allow the physician to avoid piercing the critical structures near the penile bulb nor does it provide position flexibility in the case of pubic arch interference. On CT data from ten previously-treated patients new catheters were digitized following three catheter patterns: conical, bi-conical, and fireworks. The conical patterns were used to accommodate a robotic delivery using a single entry point. The bi-conical and fireworks patterns were specifically designed to avoid the critical structures near the penile bulb. For each catheter distribution, a plan was optimized with the inverse planning algorithm, IPSA, and compared with the plan used for treatment. Irrelevant of catheter geometry, a plan must fulfill the RTOG-0321 dose criteria for target dose coverage. Results: Thirty plans from ten patients were optimized. All non-standard patterns fulfilled the RTOG criteria when the clinical plan did. In some cases, the dose distribution was improved by better sparing the organs-at-risk. Conclusion: Alternative catheter patterns can provide the physician with additional ways to treat patients previously considered unsuited for brachytherapy treatment (pubic arch interference) and facilitate robotic guidance of catheter insertion. In addition, alternative catheter patterns may decrease toxicity by avoidance of the critical structures near the penile bulb while still fulfilling the RTOG criteria.
Inverse treatment planning in radiation therapy is formulated as optimization problems. The objective function and constraints consist of multiple terms designed for different clinical and practical considerations. Weighting factors of these terms ar
e needed to define the optimization problem. While a treatment planning system can solve the optimization problem with given weights, adjusting the weights for high plan quality is performed by human. The weight tuning task is labor intensive, time consuming, and it critically affects the final plan quality. An automatic weight-tuning approach is strongly desired. The weight tuning procedure is essentially a decision making problem. Motivated by the tremendous success in deep learning for decision making with human-level intelligence, we propose a novel framework to tune the weights in a human-like manner. Using treatment planning in high-dose-rate brachytherapy as an example, we develop a weight tuning policy network (WTPN) that observes dose volume histograms of a plan and outputs an action to adjust organ weights, similar to the behaviors of a human planner. We train the WTPN via end-to-end deep reinforcement learning. Experience replay is performed with the epsilon greedy algorithm. Then we apply the trained WTPN to guide treatment planning of testing patient cases. The trained WTPN successfully learns the treatment planning goals to guide the weight tuning process. On average, the quality score of plans generated under the WTPNs guidance is improved by ~8.5% compared to the initial plan with arbitrary weights, and by 10.7% compared to the plans generated by human planners. To our knowledge, this is the first tool to adjust weights for the treatment planning in a human-like fashion based on learnt intelligence. The study demonstrates potential feasibility to develop intelligent treatment planning system via deep reinforcement learning.
Purpose: To develop a knowledge-based voxel-wise dose prediction system using a convolution neural network for high-dose-rate brachytherapy cervical cancer treatments with a tandem-and-ovoid (T&O) applicator. Methods: A 3D U-NET was utilized to outpu
t dose predictions using organ-at-risk (OAR), high-risk clinical target volume (HRCTV), and possible source locations. A sample of previous T&O treatments comprising 397 cases (273 training:62 validation:62 test), HRCTV and OARs (bladder/rectum/sigmoid) was used. Structures and dose were interpolated to 1x1x2.5mm3 dose planes with two input channels (source positions, voxel identification) and one output channel for dose. We evaluated dose difference (Delta D)(xyz)=D_(actual)(x,y,z)-D_(predicted)(x,y,z) and dice similarity coefficients in all cohorts across the clinically-relevant dose range (20-130% of prescription), mean and standard deviation. We also examined discrete DVH metrics used for T&O plan quality assessment: HRCTV D_90%(dose to hottest 90% volume) and OAR D_2cc, with Delta D_x=D_(x,actual)-D_(x,predicted). Pearson correlation coefficient, standard deviation, and mean quantified model performance on the clinical metrics. Results: Voxel-wise dose difference accuracy for 20-130% dose range for training(test) ranges for mean (Delta D) and standard deviation for all voxels was [-0.3%+/-2.0% to +1.0%+/-12.0%] ([-0.1%+/-4% to +4.0%+/-26%]). Voxel-wise dice similarity coefficients for 20-130% dose ranged from [0.96, 0.91]([0.94, 0.87]). DVH metric prediction in the training (test) set were HRCTV(Delta D_90)=-0.19+/-0.55 Gy (-0.09+/-0.67 Gy), bladder(Delta D_2cc)=-0.06+/-0.54 Gy (-0.17+/-0.67 Gy), rectum(Delta D)_2cc=-0.03+/-0.36 Gy (-0.04+/-0.46 Gy), and sigmoid(Delta D_2cc)=-0.01+/-0.34 Gy (0.00+/-0.44 Gy). Conclusion: 3D knowledge-based dose predictions for T&O brachytherapy provide accurate voxel-level and DVH metric estimates.
Purpose: This is a theoretical simulation study for proof of concept of radiochromic film dosimetry to measure physical and biological doses without plan-based quenching correction for patient-specific quality assurance of carbon-ion radiotherapy. Me
thods: We took a layer-stacking carbon-ion beam comprised of range-shifted beamlets. The dosimeter response was simulated according to an experimental quenching model. The beam model followed a treatment planning system. The beam was decomposed into finely arranged beamlets with weights estimated by deconvolution of longitudinal dosimeter responses. The distributions of physical and biological doses were reconstructed from the estimated weights, and were compared with the plan. We also evaluated the sensitivity to measurement errors and to erratic delivery with an undelivered beamlet. Results: The reconstructed physical and biological doses accurately reproduced the simulated delivery with errors approximately corresponding to the measurement errors. The erratic beam delivery was easily detectable by comparison of biological dose distribution to the plan. Conclusions: We have developed a method to measure physical and biological doses by longitudinal dosimetry of quenched response without using plan data. The method only involves a general optimization algorithm, a radiobiology model, and experimental beamlet data, and requires no extra corrections. Theoretically, this approach is applicable to various dosimeters and to proton and ion beams of any delivery method, regardless of quenching or biological effectiveness.
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
